Lv1
70 积分 2023-12-26 加入
Vorasidenib in IDH1-mutant or IDH2-mutant low-grade glioma (INDIGO): secondary and exploratory endpoints from a randomised, double-blind, placebo-controlled, phase 3 trial
1天前
待确认
Levetiracetam Reverses Temozolomide Resistance in Glioblastoma by Blocking Drug Efflux through RAB5A/CD63-RAB35 Axis
20天前
已完结
NEU1 Sustains Mitochondria-Lysosome Contacts to Trigger Lysosomal Cu²⁺/Cathepsin Escape and Mitochondrial lysis in Glioblastoma (NeuLysis)
29天前
已完结
Preserved IDH mutation and methylation class in vorasidenib nonresponders: A report of 2 cases
2个月前
已完结
Vorasidenib in IDH1-mutant or IDH2-mutant low-grade glioma (INDIGO): secondary and exploratory endpoints from a randomised, double-blind, placebo-controlled, phase 3 trial
3个月前
已完结
Microbubble-enhanced transcranial focused ultrasound with temozolomide for patients with high-grade glioma (BT008NA): a multicentre, open-label, phase 1/2 trial
5个月前
已完结
A Phase 2 PBTC Study of Selumetinib for Recurrent/Progressive Pediatric Low-Grade Glioma: Strata 2, 5, and 6 with Long-term Outcomes on Strata 1, 3, and 4
5个月前
已完结
Hypertensive Retinopathy
6个月前
已关闭
Reduced‐dose post‐transplant cyclophosphamide plus low‐dose post‐transplant anti‐thymocyte globulin as graft‐versus‐host disease prophylaxis with fludarabine–busulfan–cytarabine conditioning in haploidentical peripheral blood stem cell transplantation: A multicentre, randomized controlled clinical trial
6个月前
已完结
Advancing quality care for cirrhosis: A data-driven framework to reduce disparities and improve outcomes
7个月前
已关闭
皖公网安备34019202002308
